<?xml version="1.0" encoding="UTF-8"?>
<p id="p0015">As of the time of this writing, no effective drug to treat—or vaccine to prevent—Zika infection is licensed and available. Both are needed, yet neither was a priority to scientists or funders until the 2015 outbreaks. Now, as of this writing, some 18 known vaccine candidates are in various stages of preclinical and clinical development. Research funding has been made available, although it is clearly too little, is contributed by too few countries, and may not be sustained. In this regard, recent calls for global funding of new vaccines have proven timely.
 <xref rid="bib2" ref-type="bibr">
  <sup>2</sup>
 </xref> Lastly, there is still much to be learned about the virus’s mechanism of disease action and how it causes specific pathology across different ages, sexes, medical conditions (eg, pregnancy), and other issues—some undoubtedly yet to be defined.
</p>
